• News
  • Added Suddhir Jain, MD, Bionova: We are accelerating research and invention initiatives to establish the company as globally respected premium pharmaceutical brand, while the company is remained focused on developing its pipeline products across its business segments to sustain our long term growth.
This story is from December 10, 2014

Added Suddhir Jain, MD, Bionova: We are accelerating research and invention initiatives to establish the company as globally respected premium pharmaceutical brand, while the company is remained focused on developing its pipeline products across its business segments to sustain our long term growth.

Added Suddhir Jain, MD, Bionova: We are accelerating research and invention initiatives to establish the company as globally respected premium pharmaceutical brand, while the company is remained focused on developing its pipeline products across its business segments to sustain our long term growth.
Added Suddhir Jain, MD, Bionova: We are accelerating research and invention initiatives to establish the company as globally respected premium pharmaceutical brand, while the company is remained focused on developing its pipeline products across its business segments to sustain our long term growth.
author
About the Author
Anshul Dhamija

Anshul Dhamija is a Principal Correspondent at The Times of India, Bangalore. His focus area is to report on lifestyle trends. He also covers business news with a focus on real state, retail, biotechnology, and aviation.

End of Article
FOLLOW US ON SOCIAL MEDIA